DAPT (GSI-IX, LY-374973) _ 52104ESDAPT (GSI IX) is a novel secretase ( secretase) inhibitor that inhibits the production of total A and A42 in cells, which in turn affects cell signaling and cell differentiation. DAPT reduces the total A yield in HEK 293 cells, with an IC50 of 20 nM in HEK 293 cells. DAPT inhibits the production of A and A42 in human neurocytes respectively with IC50 of 115 nM and 200 nM, which are 5 10 fold lower than those when applied to HEK 293 cells. DAPT

IGFs are predominantly produced by the liver

also known as scatter factor and hepatopoietin A

Especially

Ala20-Phe152

Yeasen products were applied in the study by Huang K

followed by processing of the pro-enzyme into active forms

[Accession | P46531]

SPR Data: Human ICOS

This enzyme is widely used for the construction of DNA libraries and for end labeling to generate probes

And it is recommended to modify the 3 'end of the primer in the system to prevent degradation

For conventional high-quality genomic DNA

Human SLAMF7/CRACC/CD319 Protein is expressed from HEK293 with mFc (IgG1) tag at the C-Terminus